E-Therapeutics PLC - ESG Rating & Company Profile powered by AI
This analysis of E-Therapeutics PLC incorporates data from across the internet and also from available disclosures by E-Therapeutics PLC. This dashboard contains a Q&A table on E-Therapeutics PLC. Scroll down to the end of this page for potential risks for E-Therapeutics PLC based on industry, geography and size.
E-Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.7; made up of an environmental score of 2.7, social score of 6.4 and governance score of 8.0.
5.7
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
541 | Wntresearch AB | 5.8 | High |
541 | Zenotech Laboratories Ltd | 5.8 | High |
579 | E-Therapeutics PLC | 5.7 | High |
579 | Caplin Point Laboratories Ltd | 5.7 | High |
579 | Biotest AG | 5.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does E-Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Does E-Therapeutics PLC disclose current and historical energy intensity?
Does E-Therapeutics PLC report the average age of the workforce?
Does E-Therapeutics PLC reference operational or capital allocation in relation to climate change?
Does E-Therapeutics PLC disclose its ethnicity pay gap?
Does E-Therapeutics PLC disclose cybersecurity risks?
Does E-Therapeutics PLC use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does E-Therapeutics PLC offer flexible work?
Does E-Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does E-Therapeutics PLC disclose the number of employees in R&D functions?
Does E-Therapeutics PLC plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does E-Therapeutics PLC conduct supply chain audits?
Does E-Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does E-Therapeutics PLC conduct 360 degree staff reviews?
Does E-Therapeutics PLC disclose the individual responsible for D&I?
Does E-Therapeutics PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does E-Therapeutics PLC disclose current and / or historical scope 2 emissions?
Does E-Therapeutics PLC disclose water use targets?
Does E-Therapeutics PLC have careers partnerships with academic institutions?
Did E-Therapeutics PLC have a product recall in the last two years?
Does E-Therapeutics PLC disclose incidents of discrimination?
Does E-Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Has E-Therapeutics PLC issued a profit warning in the past 24 months?
Does E-Therapeutics PLC disclose parental leave metrics?
Does E-Therapeutics PLC disclose climate scenario or pathway analysis?
Does E-Therapeutics PLC disclose current and / or historical scope 1 emissions?
Does E-Therapeutics PLC explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does E-Therapeutics PLC disclose the pay ratio of women to men?
Does E-Therapeutics PLC support suppliers with sustainability related research and development?
Does E-Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does E-Therapeutics PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is E-Therapeutics PLC involved in embryonic stem cell research?
Does E-Therapeutics PLC disclose GHG and Air Emissions intensity?
Does E-Therapeutics PLC disclose its waste policy?
Does E-Therapeutics PLC report according to TCFD requirements?
Does E-Therapeutics PLC plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does E-Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does E-Therapeutics PLC disclose energy use targets?
Does E-Therapeutics PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does E-Therapeutics PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for E-Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.